Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body
- PMID: 33717063
- PMCID: PMC7953067
- DOI: 10.3389/fimmu.2021.578386
Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body
Abstract
Hosting millions of microorganisms, the digestive tract is the primary and most important part of bacterial colonization. On one side, in cases of opportunistic invasion, the abundant bacterial population inside intestinal tissues may face potential health problems such as inflammation and infections. Therefore, the immune system has evolved to sustain the host-microbiota symbiotic relationship. On the other hand, to maintain host immune homeostasis, the intestinal microflora often exerts an immunoregulatory function that cannot be ignored. A field of great interest is the association of either microbiota or probiotics with the immune system concerning clinical uses. This microbial community regulates some of the host's metabolic and physiological functions and drives early-life immune system maturation, contributing to their homeostasis throughout life. Changes in gut microbiota can occur through modification in function, composition (dysbiosis), or microbiota-host interplays. Studies on animals and humans show that probiotics can have a pivotal effect on the modulation of immune and inflammatory mechanisms; however, the precise mechanisms have not yet been well defined. Diet, age, BMI (body mass index), medications, and stress may confound the benefits of probiotic intake. In addition to host gut functions (permeability and physiology), all these agents have profound implications for the gut microbiome composition. The use of probiotics could improve the gut microbial population, increase mucus-secretion, and prevent the destruction of tight junction proteins by decreasing the number of lipopolysaccharides (LPSs). When LPS binds endothelial cells to toll-like receptors (TLR 2, 4), dendritic cells and macrophage cells are activated, and inflammatory markers are increased. Furthermore, a decrease in gut dysbiosis and intestinal leakage after probiotic therapy may minimize the development of inflammatory biomarkers and blunt unnecessary activation of the immune system. In turn, probiotics improve the differentiation of T-cells against Th2 and development of Th2 cytokines such as IL-4 and IL-10. The present narrative review explores the interactions between gut microflora/probiotics and the immune system starting from the general perspective of a biological plausibility to get to the in vitro and in vivo demonstrations of a probiotic-based approach up to the possible uses for novel therapeutic strategies.
Keywords: autism spectrum disorders; celiac disease; inflammation; inflammatory bowel disease; irritable bowel syndrome; microbiota; obesity; probiotics.
Copyright © 2021 Cristofori, Dargenio, Dargenio, Miniello, Barone and Francavilla.
Conflict of interest statement
RF is the inventor of the patent N 0001425900, released on 17 November 2016 (Italy). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7953067/bin/fimmu-12-578386-g001.gif)
Similar articles
-
Intestinal Microbiota as a Contributor to Chronic Inflammation and Its Potential Modifications.Nutrients. 2021 Oct 28;13(11):3839. doi: 10.3390/nu13113839. Nutrients. 2021. PMID: 34836095 Free PMC article. Review.
-
Interactions between Intestinal Microflora/Probiotics and the Immune System.Biomed Res Int. 2019 Nov 20;2019:6764919. doi: 10.1155/2019/6764919. eCollection 2019. Biomed Res Int. 2019. PMID: 31828119 Free PMC article. Review.
-
Dysbiosis a risk factor for celiac disease.Med Microbiol Immunol. 2017 Apr;206(2):83-91. doi: 10.1007/s00430-017-0496-z. Epub 2017 Feb 15. Med Microbiol Immunol. 2017. PMID: 28204873 Review.
-
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014. Microbiol Spectr. 2015. PMID: 26185088
-
Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.World J Gastroenterol. 2014 Nov 7;20(41):15163-76. doi: 10.3748/wjg.v20.i41.15163. World J Gastroenterol. 2014. PMID: 25386066 Free PMC article. Review.
Cited by
-
Combination therapy with probiotics and anti-PD-L1 antibody synergistically ameliorates sepsis in mouse model.Heliyon. 2024 May 22;10(11):e31747. doi: 10.1016/j.heliyon.2024.e31747. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38828304 Free PMC article.
-
Distribution characteristics of gastric mucosal colonizing microorganisms in different glandular regions of Bactrian camels and their relationship with local mucosal immunity.PLoS One. 2024 May 30;19(5):e0300316. doi: 10.1371/journal.pone.0300316. eCollection 2024. PLoS One. 2024. PMID: 38814894 Free PMC article.
-
Advances in Gut Microbiota-Targeted Therapeutics for Metabolic Syndrome.Microorganisms. 2024 Apr 24;12(5):851. doi: 10.3390/microorganisms12050851. Microorganisms. 2024. PMID: 38792681 Free PMC article. Review.
-
Lactococcus lactis subsp. cremoris C60 Upregulates Macrophage Function by Modifying Metabolic Preference in Enhanced Anti-Tumor Immunity.Cancers (Basel). 2024 May 18;16(10):1928. doi: 10.3390/cancers16101928. Cancers (Basel). 2024. PMID: 38792006 Free PMC article.
-
High-altitude-induced alterations in intestinal microbiota.Front Microbiol. 2024 May 9;15:1369627. doi: 10.3389/fmicb.2024.1369627. eCollection 2024. Front Microbiol. 2024. PMID: 38784803 Free PMC article. Review.
References
-
- Barrett R, Kuzawa CW, McDade T, Armelagos GJ. Emerging and re-emerging infectious diseases: the third epidemiologic transition. Emerg Re-emerg Infect Dis: Third Epidemiol Transition (1998) 12(6):778–87. 10.1146/annurev.anthro.27.1.247 - DOI
-
- Lochmiller RL, Deerenberg C. Trade-offs in evolutionary immunology: Just what is the cost of immunity? Oikos (2000) 88(1):87−98. 10.1034/j.1600-0706.2000.880110.x - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical